120 related articles for article (PubMed ID: 38143314)
1. SLC35A2 expression drives breast cancer progression via ERK pathway activation.
Yang X; Tao Y; Xu Y; Cai W; Shao Q
FEBS J; 2024 Apr; 291(7):1483-1505. PubMed ID: 38143314
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
3. Blocking hsa_circ_0006168 suppresses cell proliferation and motility of human glioblastoma cells by regulating hsa_circ_0006168/miR-628-5p/IGF1R ceRNA axis.
Wang T; Mao P; Feng Y; Cui B; Zhang B; Chen C; Xu M; Gao K
Cell Cycle; 2021 Jun; 20(12):1181-1194. PubMed ID: 34024251
[TBL] [Abstract][Full Text] [Related]
4. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
[No Abstract] [Full Text] [Related]
5. Aberrant Expression of Solute Carrier Family 35 Member A2 Correlates With Tumor Progression in Breast Cancer.
Liu CL; Cheng SP; Huang WC; Chen MJ; Lin CH; Chen SN; Chang YC
In Vivo; 2023; 37(1):262-269. PubMed ID: 36593004
[TBL] [Abstract][Full Text] [Related]
6. LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway.
Zhang Q; Cheng S; Cao L; Yang J; Wang Y; Chen Y
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32077915
[TBL] [Abstract][Full Text] [Related]
7. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
[TBL] [Abstract][Full Text] [Related]
8. HSA_CIRC_0004050 on proliferation and apoptosis of A549 cells through ERK/JNK signaling pathway.
Wang Y; Zang RK; Du YN
J Biol Regul Homeost Agents; 2020; 34(6):2037-2047. PubMed ID: 33348975
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner.
Wang J; Yang K; Cao J; Li L
Bioengineered; 2021 Dec; 12(2):10624-10637. PubMed ID: 34738502
[TBL] [Abstract][Full Text] [Related]
10. STARD4 promotes breast cancer cell malignancy.
Zhang M; Xiang Z; Wang F; Shan R; Li L; Chen J; Liu BA; Huang J; Sun LQ; Zhou WB
Oncol Rep; 2020 Dec; 44(6):2487-2502. PubMed ID: 33125124
[TBL] [Abstract][Full Text] [Related]
11. miR-451a suppresses the proliferation and migration of high-grade serous ovarian cancer by targeting RAB5A through the Ras/Raf/MEK/ERK pathway.
Liu S; Wang K; Zhao Z; Pang Y; Liu F; Wang P; Wang Z; Yang X
J Gene Med; 2024 Jan; 26(1):e3649. PubMed ID: 38282155
[TBL] [Abstract][Full Text] [Related]
12. hsa_circRNA_0006528 as a competing endogenous RNA promotes human breast cancer progression by sponging miR-7-5p and activating the MAPK/ERK signaling pathway.
Gao D; Qi X; Zhang X; Fang K; Guo Z; Li L
Mol Carcinog; 2019 Apr; 58(4):554-564. PubMed ID: 30520151
[TBL] [Abstract][Full Text] [Related]
13. The lncRNA HOXA11-AS acts as a tumor promoter in breast cancer through regulation of the miR-125a-5p/TMPRSS4 axis.
Xu Y; Ren Z; Wang X; Ren M
J Gene Med; 2022 May; 24(5):e3413. PubMed ID: 35106863
[TBL] [Abstract][Full Text] [Related]
14. MiR-16-5p suppresses breast cancer proliferation by targeting ANLN.
Wang Z; Hu S; Li X; Liu Z; Han D; Wang Y; Wei L; Zhang G; Wang X
BMC Cancer; 2021 Nov; 21(1):1188. PubMed ID: 34743685
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LINC00662 promotes colon cancer tumor growth and metastasis by competitively binding with miR-340-5p to regulate CLDN8/IL22 co-expression and activating ERK signaling pathway.
Cheng B; Rong A; Zhou Q; Li W
J Exp Clin Cancer Res; 2020 Jan; 39(1):5. PubMed ID: 31900207
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SOX2-OT regulates miR-192-5p/RAB2A axis and ERK pathway to promote glioblastoma cell growth.
Wang H; Hu Q; Tong Y; Li S; Chen M; Wang B; Li H
Cell Cycle; 2021 Oct; 20(19):2010-2020. PubMed ID: 34470582
[TBL] [Abstract][Full Text] [Related]
17. Association and clinicopathologic significance of p38MAPK-ERK-JNK-CDC25C with polyploid giant cancer cell formation.
Liu K; Lu R; Zhao Q; Du J; Li Y; Zheng M; Zhang S
Med Oncol; 2019 Nov; 37(1):6. PubMed ID: 31734829
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of long non-coding RNA MALAT1 inhibits granulosa cell proliferation in endometriosis by up-regulating P21 via activation of the ERK/MAPK pathway.
Li Y; Liu YD; Chen SL; Chen X; Ye DS; Zhou XY; Zhe J; Zhang J
Mol Hum Reprod; 2019 Jan; 25(1):17-29. PubMed ID: 30371869
[TBL] [Abstract][Full Text] [Related]
19. miR-18a-5p Promotes Proliferation and Migration of Vascular Smooth Muscle Cells by Activating the AKT/Extracellular Regulated Protein Kinases (ERK) Signaling Pathway.
Zhang Y; Chen X
Med Sci Monit; 2020 May; 26():e924625. PubMed ID: 32458821
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive Analysis of SLC35A2 in Pan-Cancer and Validation of Its Role in Breast Cancer.
Sun X; Yuan Z; Zhang L; Ren M; Yang J; Xu Y; Hao J
J Inflamm Res; 2023; 16():3381-3398. PubMed ID: 37593196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
